The FDA is cracking down on websites that claim to sell the underlying chemicals...
Sick patients collapsed waiting for care in the overwhelmed emergency department...
The US FDA has granted fast track designation to Edgewise Therapeutics’ EDG-5506...
BioAge Labs has secured $170m in an Series D funding round to progress the devel...
Ipsen reported that the US FDA approved the Onivyde regimen (NALIRIFOX) as a fir...
Two FDA representatives FDA spoke at the ongoing 2024 SCOPE Summit about how the...
A bipartisan group of lawmakers is seeking an investigation and sanctions agains...
A panel at the 2024 SCOPE Summit shared their experiences of setting up and runn...
The FDA has issued warning letters to two online sellers for selling unapproved ...
The partnership will focus on designing molecular glues for unspecified therapeu...
Grifols’ Phase III AdFIrst trial met its primary endpoint and the company plans ...
Sudo Biosciences secured $30m in second round of Series B funding to further the...
A Food and Drug Administration advisory panel lent its support to Abbott's new d...
Lawmakers are considering increasing doctors’ Medicare pay in an upcoming govern...
Private equity investors made only 4 investments in Medicare Advantage-related c...
While just 2,000 Alzheimer's patients are currently taking Leqembi, an additiona...
